NCT06723912 Implementation of a Health Action Process Approach-Based Program for People on Hemodialysis Treatment
| NCT ID | NCT06723912 |
| Status | Recruiting |
| Phase | — |
| Sponsor | TC Erciyes University |
| Condition | Hemodialytic Patients |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2024-10-23 |
| Primary Completion | 2025-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2024-10-23 with a primary completion date of 2025-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to determine the effect of the Health Action Process Approach (HAPA) based program on the treatment compliance and quality of life of people undergoing hemodialysis treatment. The hypotheses of the study are as follows: * The Health Action Process Approach Based Program has an effect on the treatment compliance of people undergoing hemodialysis treatment. * The Health Action Process Approach Based Program has an effect on the quality of life of people undergoing hemodialysis treatment. * The Health Action Process Approach Based Program has an impact on the results of laboratory tests and clinical parameters of people receiving hemodialysis treatment. The population of the study will consist of people receiving hemodialysis treatment in the main service building and additional service building of Kahramanmaraş Necip Fazıl City Hospital. Patients who meet the criteria of ''volunteering to participate in the study, being over the age of 18, being literate, not having any problems that may prevent communication, not having a history of neurological or psychiatric disease, being on hemodialysis treatment for at least six months, and the vascular access used for hemodialysis being effective'' will be included in the study. Written informed consent will be obtained from patients who volunteer to participate in the study. At least 32 people who meet the inclusion criteria will be included in each group. The intervention group will receive a program based on the Health Action Process Approach (HAPA). No program will be applied to the control group. The data collection tools of the study consist of the Participant Information Form, Participant Evaluation Form Based on the Health Action Process Approach, End-Stage Renal Disease Adherence Scale (ESRD-AQ), Fluid Control Scale in Hemodialysis Patients, Diet Information Scale of Hemodialysis Patients, Diet Behavior Scale of Hemodialysis Patients, Quality of Life (SF-36) Form, Laboratory Tests Follow-up Form and Homework Form. Measurements of the groups will be taken at the beginning of the study, week 6 (at the end of the program), month 3 and month 6.
Eligibility Criteria
Inclusion Criteria: * Volunteering to participate in the study * Over 18 years of age * Being literate * Not having any problems with speech, hearing or vision that may interfere with communication * No history of neurological or psychiatric disease * Being on hemodialysis treatment for at least six months * The vascular access (catheter, fistula or graft) used to administer hemodialysis is working effectively Exclusion Criteria: * Not meeting the inclusion criteria * Participation in a program based on the Health Action Process Approach related to the subject
Frequently Asked Questions
Who can join the NCT06723912 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hemodialytic Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06723912 currently recruiting?
Yes, NCT06723912 is actively recruiting participants. Visit ClinicalTrials.gov or contact TC Erciyes University to inquire about joining.
Where is the NCT06723912 trial being conducted?
This trial is being conducted at Kahramanmaraş, Turkey (Türkiye).
Who is sponsoring the NCT06723912 clinical trial?
NCT06723912 is sponsored by TC Erciyes University. The trial plans to enroll 64 participants.